See also this year's filing and all EDGAR filings for this company.
PDF Report 0001358403_2016_Bellicum_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001358403, Bellicum Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 96,890,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,882,000 |
| 3 | remainder_Assets | 56,634,000 |
| 4 | LiabilitiesCurrent | 7,445,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 944,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,672,000 |
| 9 | ResearchAndDevelopmentExpense | 33,561,000 |
| 10 | remainder_Expenses | 3,184,000 |
| 11 | remainder_Revenues | 282,000 |
| 12 | remainder_NetIncome | 587,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 160,406,000 |
| 1 | Liabilities | 8,389,000 |
| 2 | Expenses | 49,417,000 |
| 3 | Revenues | 282,000 |
| 4 | StockholdersEquity | 152,017,000 |
| 5 | NetIncome | -48,548,000 |
| 6 | ComprehensiveNetIncome | -48,548,000 |
| 7 | BaseVar | 109,540,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.35 |
| 9 | EconomicCapitalRatio | 3.93 |